Université de Franche-Comté, Laboratoire de Biochimie, EA3922, Expression Génique et Pathologies du Système Nerveux Central, SFRIBCT FED 4234, UFR Sciences et Techniques, Besançon, France.
Epigenetics. 2013 Mar;8(3):237-45. doi: 10.4161/epi.23790. Epub 2013 Jan 30.
Estrogen signaling is mediated by ERα and ERβ in hormone dependent, breast cancer (BC). Over the last decade the implication of epigenetic pathways in BC tumorigenesis has emerged: cancer-related epigenetic modifications are implicated in both gene expression regulation, and chromosomal instability. In this review, the epigenetic-mediated estrogen signaling, controlling both ER level and ER-targeted gene expression in BC, are discussed: (1) ER silencing is frequently observed in BC and is often associated with epigenetic regulations while chemical epigenetic modulators restore ER expression and increase response to treatment;(2) ER-targeted gene expression is tightly regulated by co-recruitment of ER and both coactivators/corepressors including HATs, HDACs, HMTs, Dnmts and Polycomb proteins.
雌激素信号由 ERα 和 ERβ 在激素依赖性乳腺癌(BC)中介导。在过去的十年中,表观遗传途径在 BC 肿瘤发生中的作用已经显现出来:癌症相关的表观遗传修饰既涉及基因表达调控,也涉及染色体不稳定性。在这篇综述中,讨论了表观遗传介导的雌激素信号,控制 BC 中的 ER 水平和 ER 靶向基因表达:(1)ER 沉默在 BC 中经常观察到,并且通常与表观遗传调节有关,而化学表观遗传调节剂恢复 ER 表达并增加对治疗的反应;(2)ER 靶向基因表达受到 ER 和包括 HATs、HDACs、HMTs、Dnmts 和 Polycomb 蛋白在内的共激活剂/共抑制剂的共同募集的严格调控。